يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Acinetobacter drug effects"', وقت الاستعلام: 1.04s تنقيح النتائج
  1. 1

    المصدر: Nature Reviews Microbiology, Vol. 18, No 5 (2020) pp. 286-298

  2. 2

    المساهمون: DURDU, BÜLENT, [Balkan, Ilker Inanc] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey -- [Batirel, Ayse -- Ozer, Serdar] Kartal Dr Lutfi Kirdar Educ & Res Hosp, Istanbul, Turkey -- [Agalar, Canan -- Alici, Ozlem] Fatih Sultan Mehmet Educ & Res Hosp, Istanbul, Turkey -- [Arslan, Ferhat] Istanbul Medipol Univ, Fac Med, Istanbul, Turkey -- [Aslan, Turan] Bezmi Alem Univ, Fac Med, Istanbul, Turkey -- [Engin, Derya Ozturk] Haydarpasa Numune Educ & Res Hosp, Istanbul, Turkey -- [Bekiroglu, Nural] Marmara Univ, Fac Med, Istanbul, Turkey -- [Durdu, Bulent] Bakirkoy Sadi Konuk Educ & Res Hosp, Istanbul, Turkey -- [Turhan, Vedat] GATA Haydarpasa Educ & Res Hosp, Istanbul, Turkey -- [Karabay, Oguz -- Guciu, Ertugrul] Sakarya Univ, Fac Med, Sakarya, Turkey -- [Akalin, Serife] Pamukkale Univ, Fac Med, Denizli, Turkey -- [Alp, Emine -- Kilic, Aysegul Ulu] Erciyes Univ, Fac Med, Kayseri, Turkey -- [Altay, Fatma Aybala] Diskapi Educ & Res Hosp, Ankara, Turkey -- [Altin, Nilgun -- Cesur, Salih] Ankara Etlik Educ & Res Hosp, Ankara, Turkey -- [Celik, Aygul Dogan] Trakya Univ, Fac Med, Edirne, Turkey -- [Dogan, Mustafa] Namik Kemal Univ, Fac Med, Tekirdag, Turkey -- [Duygu, Fazilet] Gaziosmanpasa Univ, Fac Med, Tokat, Turkey -- [Engin, Aynur] Cumhuriyet Univ, Fac Med, Sivas, Turkey -- [Gonen, Ibak] Suleyman Demirel Univ, Fac Med, TR-32200 Isparta, Turkey -- [Guven, Tumer] Ankara Ataturk Educ & Res Hosp, Ankara, Turkey -- [Hatipogiu, Cigdem Ataman] Ankara Educ & Res Hosp, Ankara, Turkey -- [Hosoglu, Salih] Dicle Univ, Fac Med, Diyarbakir, Turkey -- [Karahocagil, Mustafa Kasim] Yuzuncu Yil Univ, Fac Med, Van, Turkey -- [Ormen, Bahar] Izmir Ataturk Educ & Res Hosp, Izmir, Turkey -- [Ozdemir, Davut -- Sezak, Nurbanu -- Turker, Nesrin] Duzce Univ, Educ & Res Hosp, Duzce, Turkey -- [Oztoprak, Nefise] Antalya Educ & Res Hosp, Antalya, Turkey -- [Yilmaz, Hava] Ondokuz Mayis Univ, Fac Med, Samsun, Turkey, Durdu, Bulent -- 0000-0002-0244-4006, Karabay, Oguz -- 0000-0003-0502-432X, altay, fatma aybala -- 0000-0002-7149-2968, OMÜ, Balkan, Ilker Inanc, Batirel, Ayse, Karabay, Oguz, Agalar, Canan, Akalin, Serife, Alici, Ozlem, Alp, Emine, Altay, Fatma Aybala, Altin, Nilgun, Arslan, Ferhat, Aslan, Turan, Bekiroglu, Nural, Cesur, Salih, Celik, Aygul Dogan, Dogan, Mustafa, Durdu, Bulent, Duygu, Fazilet, Engin, Aynur, Engin, Derya Ozturk, Gonen, Ibak, Guciu, Ertugrul, Guven, Tumer, Hatipogiu, Cigdem Ataman, Hosoglu, Salih, Karahocagil, Mustafa Kasim, Kilic, Aysegul Ulu, Ormen, Bahar, Ozdemir, Davut, Ozer, Serdar, Oztoprak, Nefise, Sezak, Nurbanu, Turhan, Vedat, Turker, Nesrin, Yilmaz, Hava, Balkan, II, Batirel, A, Karabay, O, Agalar, C, Akalin, S, Alici, O, Alp, E, Altay, FA, Altin, N, Arslan, F, Aslan, T, Bekiroglu, N, Cesur, S, Celik, AD, Dogan, M, Durdu, B, Duygu, F, Engin, A, Engin, DO, Gonen, I, Guciu, E, Guven, T, Hatipogiu, CA, Hosoglu, S, Karahocagil, MK, Kilic, AU, Ormen, B, Ozdemir, D, Ozer, S, Oztoprak, N, Sezak, N, Turhan, V, Turker, N, Yilmaz, H, Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü, Karabay, Oğuz, Güçlü, Ertuğrul

    المصدر: Indian Journal of Pharmacology

    مصطلحات موضوعية: Male, Kaplan Meier method, Turkey, retrospective study, proportional hazards model, Antibiotics, Bacteremia, Comorbidity, Tertiary Care Centers, middle aged, chi square distribution, Pharmacology (medical), colistin, comparative study, APACHE, Aged, 80 and over, OUTCOMES, Acinetobacter/*drug effects/pathogenicity, Acinetobacter Infections/*drug therapy/microbiology/mortality, Adolescent, Adult, Aged, Anti-Bacterial Agents/adverse effects/*therapeutic use, Bacteremia/*drug therapy/microbiology/mortality, Chi-Square Distribution, Colistin/adverse effects/*therapeutic use, Drug Resistance, Multiple, Bacterial, Drug Therapy, Combination, Female, Humans, Kaplan-Meier Estimate, Length of Stay, Middle Aged, Multivariate Ana, adult, Remission Induction, Appropriate, clinical trial, ANTIMICROBIAL THERAPY, multi drug resistant Acinetobacter spp, antiinfective agent, Pitt bacteremia score, aged, Impact, multivariate analysis, Sulbactam, risk factor, monotherapy, pathogen clearance, Baumannii Bacteremia, hospitalization, Acinetobacter Infections, medicine.medical_specialty, bloodstream infection, Article, multidrug resistance, multidrug resistant Acinetobacter bloodstream infection, human, treatment failure, Retrospective Studies, Pharmacology, Proportional hazards model, microbiology, medicine.disease, major clinical study, mortality, disease assessment, drug efficacy, multicenter study, RISK-FACTORS, TIGECYCLINE, Colistin, Acinetobacter infection, Pediatrics, BAUMANNII BACTEREMIA, Time Factors, IMPACT, very elderly, Critically-Ill Patients, Turkey (republic), Risk Factors, time factor, Risk-Factors, pathogenicity, Pharmacology & Pharmacy, Univariate analysis, biology, Acinetobacter, MATCHED COHORT, Anti-Bacterial Agents, Blood stream infection, female, Treatment Outcome, young adult, tertiary care center, CRITICALLY-ILL PATIENTS, Charlson Comorbidity Index, medicine.drug, Research Article, combination drug therapy, medicine.drug_class, Outcomes, Young Adult, remission, length of stay, Internal medicine, Gram-Negative Bacteria, medicine, follow up, controlled study, GRAM-NEGATIVE BACTERIA, A Multicenter retrospective analysis-, INDIAN JOURNAL OF PHARMACOLOGY, cilt.47, ss.95-100, 2015 [Balkan I. I. , BATIREL A., Karabay O., AGALAR C., Akalin S., ALICI O., Alp E., ALTAY F. A. , ALTIN N., Arslan F., et al., -Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections], Proportional Hazards Models, Antimicrobial Therapy, business.industry, Retrospective cohort study, Multi drug resistant Acinetobacter spp, biology.organism_classification, drug effects, Multivariate Analysis, business

    وصف الملف: application/pdf

  3. 3

    المساهمون: Service de microbiologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Biologie des Bactéries pathogènes à Gram-positif, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Centre de Référence du Pneumocoque, Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Institut Cochin (IC UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de Bactériologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Recherche des Cordeliers (CRC (UMR_S 872)), Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), This study was supported by a subvention of the Institut de Veille Sanitaire to the CNRP and by an INSERM grant., Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Européen Georges Pompidou [APHP] ( HEGP ), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique ( CNRS ), Hôpital Européen Georges Pompidou [APHP] ( HEGP ), Institut Cochin ( UM3 (UMR 8104 / U1016) ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Cochin [AP-HP], Centre de Recherche des Cordeliers ( CRC (UMR_S 872) ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS )

    المصدر: Antimicrobial Agents and Chemotherapy
    Antimicrobial Agents and Chemotherapy, 2012, 56 (10), pp.5040-5045. ⟨10.1128/aac.00939-12⟩
    Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2012, 56 (10), pp.5040-5045. ⟨10.1128/aac.00939-12⟩
    Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2012, 56 (10), pp.5040-5045. 〈10.1128/aac.00939-12〉

    مصطلحات موضوعية: MESH: Tetracycline Resistance, MESH: Acinetobacter/drug effects, Mutant, MESH: Burkholderia/ultrastructure, MESH: Pseudomonas/drug effects, Oligosaccharides, [ SDV.MP.BAC ] Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, MESH: Burkholderia/metabolism, medicine.disease_cause, Microscopy, Atomic Force, Glucuronic Acid, MESH: Anti-Bacterial Agents/pharmacology, MESH: Acinetobacter/metabolism, MESH: Microscopy, Confocal, Pharmacology (medical), MESH : Biofilms/drug effects, MESH: Microscopy, Atomic Force, 0303 health sciences, Microscopy, Confocal, biology, Acinetobacter, Hexuronic Acids, Tetracycline Resistance, MESH : Hexuronic Acids/chemistry, 3. Good health, Anti-Bacterial Agents, MESH : Acinetobacter/ultrastructure, Infectious Diseases, Streptococcus pneumoniae, MESH: Acinetobacter/ultrastructure, MESH : Anti-Bacterial Agents/pharmacology, MESH : Glucuronic Acid/chemistry, MESH : Burkholderia/ultrastructure, MESH: Bacterial Proteins/metabolism, MESH: Alginates/chemistry, medicine.drug, Tetracycline, Alginates, Burkholderia, MESH: Hexuronic Acids/chemistry, Enterococcus faecalis, Microbiology, Frameshift mutation, MESH: Glucuronic Acid/chemistry, 03 medical and health sciences, MESH : Streptococcus pneumoniae/metabolism, Bacterial Proteins, Mechanisms of Resistance, Pseudomonas, MESH : Burkholderia/drug effects, medicine, MESH : Microscopy, Confocal, Gene, 030304 developmental biology, MESH: Biofilms/drug effects, Pharmacology, MESH : Acinetobacter/metabolism, Reporter gene, MESH : Tetracycline Resistance, MESH: Burkholderia/drug effects, 030306 microbiology, MESH: Oligosaccharides/chemical synthesis, Promoter, MESH: Streptococcus pneumoniae/metabolism, MESH : Burkholderia/metabolism, biochemical phenomena, metabolism, and nutrition, biology.organism_classification, Molecular biology, [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, MESH : Microscopy, Atomic Force, MESH : Pseudomonas/drug effects, MESH : Acinetobacter/drug effects, MESH : Bacterial Proteins/metabolism, Biofilms, MESH : Oligosaccharides/chemical synthesis, MESH : Alginates/chemistry